Intercept Pharmaceuticals reported $758K in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Acorda Therapeutics ACOR:US $ 5.97M 1.77M
Alnylam Pharmaceuticals ALNY:US $ 35.63M 2.04M
Amarin AMRN:US $ 22.24M 8.4M
Amgen AMGN:US $ 1561M 157M
AstraZeneca AZN:LN 2279M 790M
Biogen BIIB:US $ 753.9M 93.8M
Bristol Myers Squibb BMY:US $ 2471M 115M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
Gilead Sciences GILD:US $ 1424M 1203M
GlaxoSmithKline GSK:LN 3645M 30M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
IONIS PHARMACEUT IONS:US $ 4.17M 1.94M
Moderna Inc MRNA:US 1.02B 65M
Neurocrine Biosciences NBIX:US $ 4.6M 0.5M
Novartis NOVN:VX SF 3755M 245M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Sarepta Therapeutics SRPT:US $ 31.44M 0.3M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M
YTE INCY:US $ 37.21M 1.36M